Skip to content

NAGE NAGE Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

eXoZymes Inc. Common Stock logo
eXoZymes Inc. Common StockEXOZ
$0-100%
Abbott logo
AbbottABT
$116M-59.6%
FitLife Brands, Inc. logo
FitLife Brands, Inc.FTLF
$0-100%
Olaplex Holdings, Inc. logo
Olaplex Holdings, Inc.OLPX
$227K-56.9%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$2.2M-13.1%
Darling Ingredients Inc. logo
Darling Ingredients Inc.DAR
$2.56M+649%

Other financials

Income statement

See full
Revenue$31.5M+3.3%
Gross profit$20.0M+3.3%
Operating income$1.6M-67.0%
Net income$6.3M+24.8%
EPS (diluted)$0.07+16.7%

Balance sheet

See full
Cash & equivalents$66.5M+19.7%
Total debt$2.6M-26.9%
Total equity$82.3M+48.8%
Total assets$114.3M+40.6%

Cash flow

See full
Operating cash flow-$1.2M-115%

Valuation

See full
Market cap$254.07M-74.9%
Enterprise value$190.09M-79.7%
P/E13.6×-43.5×
P/S-6.8×

Profitability

See full
Gross margin64.3%+1.8pp
Operating margin10%-2.2pp
Net margin14.3%+1.2pp
FCF margin-70.4%

Returns & leverage

See full
Return on equity27.1%-6.4pp
Debt / equity0.0×
Current ratio4.6×+0.9×

Where this comes from

Reported directly by NAGE in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NAGE's stock issuance proceeds?
NAGE (NAGE) reported stock issuance proceeds of $111K in Q1 2026.
How has NAGE's stock issuance proceeds changed year-over-year?
NAGE's stock issuance proceeds decreased by 96.4% year-over-year, from $3.11M to $111K.
What is the long-term trend for NAGE's stock issuance proceeds?
Over 3 years (2021 to 2025), NAGE's stock issuance proceeds has grown at a -35.3% compound annual growth rate (CAGR), from $26.74M to $7.25M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.